RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding RAPT Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 96 | 1 | 109 | +14 |
| Shares | 34.8M | 10.3K | 35.0M | +229.0K (+0.7%) |
| Value | $577.8M | $171.2K | $869.3M | +$291.7M (+50.5%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (8)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Boxer Capital, LLC | 300,000 | $4.99M |
| Qube Research & Technologies Ltd | 39,843 | $662.2K |
| Cheyne Capital Management (UK) LLP | 20,000 | $332.4K |
| Allianz Asset Management GmbH | 18,100 | $300.8K |
| Simplex Trading, LLC | 669 | $11.0K |
| Russell Investments Group, Ltd. | 581 | $9.66K |
| Signaturefd, LLC | 33 | $548 |
| Allworth Financial LP | 13 | $217 |
Not filed for Q4 2023 yet (1)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Virginia Retirement Systems Et Al | 10,300 | $171.2K |